Additional mechanistic investigations have implicated BPC-157 in the modulation of the FAK-paxillin pathway, a key regulator of focal adhesion dynamics and cytoskeletal organization
The 50 mg vial is reconstituted with 2 mL of bacteriostatic water to achieve a 25 mg/mL concentration (0.25 mg per unit)
It also provides a sustained increase in hormone and IGF-1 levels
From the digestive system: frequency not established nausea, vomiting, diarrhea, abdominal pain
Table of Contents What Is Retatrutide and Its Role in Weight Loss Treatment Understanding Retatrutide Reconstitution: Important Safety Information Reconstitution Calculators: Why They Are Not Appropriate for Patient Use Dosing Considerations and MHRA Safety Guidance Risks of Incorrect Reconstitution and When to Seek Advice Accessing Weight Loss Medicines Safely Through UK Healthcare Scientific References Frequently Asked Questions What Is Retatrutide and Its Role in Weight Loss Treatment Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, and glucagon) not yet licensed by the MHRA or EMA, meaning it cannot legally be prescribed or supplied as a medicine in the UK outside approved clinical trials
We do ask that before booking, you read the information on this page, and if you suspect you have low B12 but its unconfirmed, contact your GP for investigations